Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01250223||Active, not recruiting||Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)||
||1093||All||18 Years and older (Adult, Senior)||NCT01250223||F2-study||February 2003||May 2008||December 2016||November 30, 2010||January 6, 2016||
|2||NCT02008006||Recruiting||BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)||
||50||All||18 Years to 65 Years (Adult)||NCT02008006||BENEFIT
|BENEFIT||July 9, 2014||July 2018||January 2022||December 11, 2013||August 4, 2017||